nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—uterine cervix—vaginal cancer	0.151	0.151	CbGeAlD
Trimetrexate—DHFR—urethra—vaginal cancer	0.138	0.138	CbGeAlD
Trimetrexate—DHFR—endometrium—vaginal cancer	0.136	0.136	CbGeAlD
Trimetrexate—DHFR—mammalian vulva—vaginal cancer	0.132	0.132	CbGeAlD
Trimetrexate—DHFR—uterus—vaginal cancer	0.126	0.126	CbGeAlD
Trimetrexate—DHFR—female reproductive system—vaginal cancer	0.113	0.113	CbGeAlD
Trimetrexate—DHFR—female gonad—vaginal cancer	0.103	0.103	CbGeAlD
Trimetrexate—DHFR—vagina—vaginal cancer	0.102	0.102	CbGeAlD
